Science

One of my microbiology professors stated we treat symptoms since its much easier plus creates repeat patients/customers. At this stage in the game though the focus shouldn't be on symptoms but genetics without question. Solving genetic variations resulting in too much or too little output of biochemicals is currently possible for select diseases yet results in a one time customer. Due to this aspect, the field of genetic repair has never been an area of true interest for the big spenders as they tend to care much more about the bottom line than their patients.